Orphan Drugs of the Future?

See allHide authors and affiliations

Science  19 Mar 2004:
Vol. 303, Issue 5665, pp. 1798
DOI: 10.1126/science.303.5665.1798

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution


Antibiotics are rapidly becoming the stepchild of the pharmaceutical industry. And infectious-disease specialists are sounding an alarm.